DRUGS USED FOR BLOOD COAGULATION DISORDERS by Margaret M.Silwimba - B-Pharm, Msc Clin. pharmacy-unza

Description

These comprehensive lecture notes cover Drugs used for Blood Coagulation Disorders, authored by Margaret M. Silwimba, a clinical pharmacy specialist with a B.Pharm and MSc. The material begins by outlining the physiological role of hemostasis and the delicate balance between blood fluidity and coagulation, explaining the intrinsic, extrinsic, and common pathways of the clotting cascade and the process of fibrinolysis. It details thromboembolic disorders, such as arterial and venous thrombosis, and bleeding disorders like thrombocytopenia and hemophilia. The pharmacotherapy section is systematically divided into three main drug classes. Anticoagulants, including antithrombin-dependent agents like Heparin and Low-Molecular-Weight Heparin (LMWH), direct thrombin inhibitors (e.g., Hirudin, Argatroban), and oral anticoagulants like Warfarin, are explained with their mechanisms, monitoring parameters (aPTT, PT), indications, and adverse effects. Antiplatelet drugs (e.g., Aspirin, Clopidogrel) are described as agents that inhibit platelet aggregation to prevent arterial thrombosis. Fibrinolytic drugs (e.g., Streptokinase, Alteplase) are covered as plasminogen activators used to dissolve existing clots in conditions like acute myocardial infarction. The notes also address the management of bleeding disorders with Vitamin K, fibrinolytic inhibitors (e.g., Tranexamic Acid), and plasma fractions like Factor VIII for hemophilia. This resource is an essential study aid for tertiary-level students in pharmacology, pharmacy, and biomedical sciences, providing a detailed and structured overview of coagulation modifiers for examination preparation and clinical understanding. Review this material to master the pharmacology of drugs used in coagulation disorders.